EUVIMEDSkopri EUVIMED
Fall-Kontroll-Studie

Gut Dysbiosis and Diabetic Nephropathy Progression in Patients with Type 2 Diabetes: A Case-Control Study

Alaa Mohamed Rabea, Mohamed Elsheikh, Radwa Ahmed Rabea Abdel-Latif, May S. Soliman, Amani El-Kholy, Ahmed Amin Ibrahim, Khaled Elsayed Elhadidy, Mahmoud Hassan

Clinical Diabetology · 2024

DOI: 10.5603/cd.100031 ↗

At a glance

Fall-Kontroll-Studie in Clinical Diabetology, 2024. Written by Alaa Mohamed Rabea and 7 co-authors. Cited 1 times so far (Crossref).

AstrattDettalji biblijografiċiCiteRelated studies

Abstract (original language)

OBJECTIVE: Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD). There is growing evidence that intestinal dysbiosis is associated with various disorders. This study aimed to investigate the associations between the human gut microbiome and the development of DN. MATERIALS AND METHODS: This case-control study was carried out on 75 subjects, both sexes, divided into 3 equal groups (n = 25): Group I consisted of healthy participants; Group II included individuals who had type 2 diabetes (T2D) but no nephropathy; and Group III was identified as having DN based on a urine albumin creatinine ratio of 30 mg/g or above. DNA extraction using PCR amplification and 16S rRNA gene sequencing were used to analyze the fecal microbiota. RESULTS: Twenty-five healthy controls (12 women and 13 men) had a mean age of 45 ± 8.77 years. Of the 25 patients with T2D, 11 were females, 14 were males, and the mean age was 45 ± 6.68 years. The average age of the 25 DN patients (10 females and 15 males) was 45 ± 6.68 years. Urinary albumin creatinine ratios were found to positively correlate with Escherichia-Shigella (r = 0.88, p-value < 0.002) and Alistipes (r = 0.91, p < 0.0001), respectively. A negative association (r = –0.77, p-value < 0.0001) was detected between the [Ruminococcus] torques group and the estimated glomerular filtration rate (eGFR). CONCLUSIONS: Unbalanced gut microbiota significantly correlates with clinical markers of renal function, cholesterol, blood albumin, and urine albumin creatinine ratio.

Cite

APA

Rabea, A. M., Elsheikh, M., Abdel-Latif, R. A. R., Soliman, M. S., El-Kholy, A., Ibrahim, A. A., Elhadidy, K. E., & Hassan, M. (2024). Gut Dysbiosis and Diabetic Nephropathy Progression in Patients with Type 2 Diabetes: A Case-Control Study. Clinical Diabetology. https://doi.org/10.5603/cd.100031

Vancouver

Rabea AM, Elsheikh M, Abdel-Latif RAR, Soliman MS, El-Kholy A, Ibrahim AA, et al. Gut Dysbiosis and Diabetic Nephropathy Progression in Patients with Type 2 Diabetes: A Case-Control Study. Clinical Diabetology. 2024. doi:10.5603/cd.100031

BibTeX
@article{Rabea2024,
  author = {Rabea, Alaa Mohamed and Elsheikh, Mohamed and Abdel-Latif, Radwa Ahmed Rabea and Soliman, May S. and El-Kholy, Amani and Ibrahim, Ahmed Amin and Elhadidy, Khaled Elsayed and Hassan, Mahmoud},
  title = {Gut Dysbiosis and Diabetic Nephropathy Progression in Patients with Type 2 Diabetes: A Case-Control Study},
  journal = {Clinical Diabetology},
  year = {2024},
  doi = {10.5603/cd.100031}
}
Start for free →